STOCK TITAN

[144] Artivion, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Artivion filed a Form 144 reporting a proposed sale of 7,992 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $307,612.08. The filing lists total shares outstanding as 47,183,658 and shows the securities were acquired on 08/08/2025 via a stock option exercise with payment made in cash.

The filer reports “Nothing to Report” for sales in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information. The notice is a formal Rule 144 disclosure of a planned insider sale.

Artivion ha depositato un Form 144 segnalando la proposta di vendita di 7,992 azioni di azioni ordinarie tramite Morgan Stanley Smith Barney LLC sul NYSE, per un valore di mercato complessivo di $307,612.08. Il deposito indica un totale di azioni in circolazione pari a 47,183,658 e riporta che i titoli sono stati acquisiti il 08/08/2025 tramite un esercizio di opzione su azioni con pagamento in contanti.

Il dichiarante segnala "Nothing to Report" per vendite negli ultimi tre mesi e include la consueta dichiarazione che il venditore non è a conoscenza di informazioni negative rilevanti non divulgate. La notifica costituisce una comunicazione formale ai sensi della Rule 144 relativa a una vendita pianificata da un insider.

Artivion presentó un Form 144 informando una venta propuesta de 7,992 acciones ordinarias a través de Morgan Stanley Smith Barney LLC en la NYSE, con un valor de mercado agregado de $307,612.08. El archivo indica que el total de acciones en circulación es de 47,183,658 y muestra que los títulos fueron adquiridos el 08/08/2025 mediante un ejercicio de opción sobre acciones con pago en efectivo.

El declarante reporta "Nothing to Report" respecto a ventas en los últimos tres meses e incluye la representación estándar de que el vendedor no tiene conocimiento de información adversa material no divulgada. La notificación es una divulgación formal conforme a la Rule 144 sobre una venta planificada por un insider.

Artivion은 NYSE에서 Morgan Stanley Smith Barney LLC를 통해 총 시장가치 $307,612.08에 해당하는 보통주 7,992주의 매각 예정 신고를 담은 Form 144를 제출했습니다. 제출서에는 총 발행주식 수를 47,183,658로 기재하고 있으며, 해당 증권은 08/08/2025스톡옵션 행사로 취득되었고 대금은 현금으로 지급되었다고 명시되어 있습니다.

신고인은 최근 3개월간의 매각에 대해 "Nothing to Report"로 보고했으며, 매도자가 미공개된 중대한 불리한 정보를 인지하고 있지 않다는 표준 진술을 포함하고 있습니다. 이 통지는 내부자 매각 계획에 대한 Rule 144에 따른 정식 공시입니다.

Artivion a déposé un Formulaire 144 signalant une proposition de vente de 7,992 actions ordinaires via Morgan Stanley Smith Barney LLC sur le NYSE, pour une valeur de marché globale de $307,612.08. Le dépôt indique le nombre total d'actions en circulation à 47,183,658 et précise que les titres ont été acquis le 08/08/2025 par un exercice d'option sur actions avec paiement en espèces.

Le déclarant indique "Nothing to Report" pour les ventes des trois derniers mois et inclut la représentation standard selon laquelle le vendeur n'a pas connaissance d'informations défavorables importantes non divulguées. L'avis constitue une divulgation formelle en vertu de la Rule 144 concernant une vente prévue par un initié.

Artivion hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 7,992 Aktien der Stammaktien über Morgan Stanley Smith Barney LLC an der NYSE mit einem aggregierten Marktwert von $307,612.08 meldet. Die Einreichung nennt die insgesamt ausstehenden Aktien als 47,183,658 und weist aus, dass die Wertpapiere am 08/08/2025 durch Ausübung einer Aktienoption erworben wurden, wobei die Zahlung in Bargeld erfolgte.

Der Einreicher gibt für Verkäufe in den letzten drei Monaten "Nothing to Report" an und enthält die übliche Zusicherung, dass dem Verkäufer keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind. Die Mitteilung ist eine formelle Offenlegung gemäß Rule 144 über einen geplanten Insider-Verkauf.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider exercised options and filed a Form 144 to sell 7,992 shares; filing discloses cash payment and broker details.

The Form 144 documents an insider sale tied to a stock option exercise executed and paid in cash on 08/08/2025. The sale is to be routed through Morgan Stanley Smith Barney LLC on the NYSE and the filing reports aggregate market value of $307,612.08. The filer reports no other sales in the prior three months. From a financial perspective, this is a standard disclosure of an insider liquidity event; the filing provides transparency on timing, quantity, and payment method.

TL;DR: Routine Rule 144 notice reflecting an option exercise and planned sale; includes seller certification about undisclosed material information.

The document is a formal Rule 144 notice showing the insider exercised options and intends to sell the resulting 7,992 shares. The filing includes the required certification that the seller is not aware of material adverse information and references Rule 10b5-1 plan adoption language without providing a plan date. It is a governance-compliant disclosure of an insider transaction; no regulatory exceptions or qualifications are disclosed within the form.

Artivion ha depositato un Form 144 segnalando la proposta di vendita di 7,992 azioni di azioni ordinarie tramite Morgan Stanley Smith Barney LLC sul NYSE, per un valore di mercato complessivo di $307,612.08. Il deposito indica un totale di azioni in circolazione pari a 47,183,658 e riporta che i titoli sono stati acquisiti il 08/08/2025 tramite un esercizio di opzione su azioni con pagamento in contanti.

Il dichiarante segnala "Nothing to Report" per vendite negli ultimi tre mesi e include la consueta dichiarazione che il venditore non è a conoscenza di informazioni negative rilevanti non divulgate. La notifica costituisce una comunicazione formale ai sensi della Rule 144 relativa a una vendita pianificata da un insider.

Artivion presentó un Form 144 informando una venta propuesta de 7,992 acciones ordinarias a través de Morgan Stanley Smith Barney LLC en la NYSE, con un valor de mercado agregado de $307,612.08. El archivo indica que el total de acciones en circulación es de 47,183,658 y muestra que los títulos fueron adquiridos el 08/08/2025 mediante un ejercicio de opción sobre acciones con pago en efectivo.

El declarante reporta "Nothing to Report" respecto a ventas en los últimos tres meses e incluye la representación estándar de que el vendedor no tiene conocimiento de información adversa material no divulgada. La notificación es una divulgación formal conforme a la Rule 144 sobre una venta planificada por un insider.

Artivion은 NYSE에서 Morgan Stanley Smith Barney LLC를 통해 총 시장가치 $307,612.08에 해당하는 보통주 7,992주의 매각 예정 신고를 담은 Form 144를 제출했습니다. 제출서에는 총 발행주식 수를 47,183,658로 기재하고 있으며, 해당 증권은 08/08/2025스톡옵션 행사로 취득되었고 대금은 현금으로 지급되었다고 명시되어 있습니다.

신고인은 최근 3개월간의 매각에 대해 "Nothing to Report"로 보고했으며, 매도자가 미공개된 중대한 불리한 정보를 인지하고 있지 않다는 표준 진술을 포함하고 있습니다. 이 통지는 내부자 매각 계획에 대한 Rule 144에 따른 정식 공시입니다.

Artivion a déposé un Formulaire 144 signalant une proposition de vente de 7,992 actions ordinaires via Morgan Stanley Smith Barney LLC sur le NYSE, pour une valeur de marché globale de $307,612.08. Le dépôt indique le nombre total d'actions en circulation à 47,183,658 et précise que les titres ont été acquis le 08/08/2025 par un exercice d'option sur actions avec paiement en espèces.

Le déclarant indique "Nothing to Report" pour les ventes des trois derniers mois et inclut la représentation standard selon laquelle le vendeur n'a pas connaissance d'informations défavorables importantes non divulguées. L'avis constitue une divulgation formelle en vertu de la Rule 144 concernant une vente prévue par un initié.

Artivion hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 7,992 Aktien der Stammaktien über Morgan Stanley Smith Barney LLC an der NYSE mit einem aggregierten Marktwert von $307,612.08 meldet. Die Einreichung nennt die insgesamt ausstehenden Aktien als 47,183,658 und weist aus, dass die Wertpapiere am 08/08/2025 durch Ausübung einer Aktienoption erworben wurden, wobei die Zahlung in Bargeld erfolgte.

Der Einreicher gibt für Verkäufe in den letzten drei Monaten "Nothing to Report" an und enthält die übliche Zusicherung, dass dem Verkäufer keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind. Die Mitteilung ist eine formelle Offenlegung gemäß Rule 144 über einen geplanten Insider-Verkauf.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Artivion (AORT) report in this Form 144?

The filing reports a proposed sale of 7,992 common shares via Morgan Stanley Smith Barney LLC with aggregate market value $307,612.08.

When will the sale reported on the AORT Form 144 occur?

The approximate date of sale listed in the filing is 08/08/2025.

How were the shares being sold acquired according to the filing?

The securities were acquired on 08/08/2025 by stock option exercise and payment was made in cash.

Who is the broker handling the proposed sale for AORT?

The filing names Morgan Stanley Smith Barney LLC as the broker.

Did the filer report any other sales of Artivion securities in the past three months?

The filing states “Nothing to Report” for securities sold during the past three months.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

1.52B
37.67M
5.01%
98.51%
2.89%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW